350 results
In this EBM Focus article, DynaMed® editors discuss a new trial attempting to determine which screening strategy is best for gestational diabetes.
In this EBM Focus article, DynaMed® editors discuss the impressive effects of semaglutide on weight loss and the limitations of this new study.
With millions of people around the world vaccinated with an mRNA-based vaccine for COVID-19, here’s a sneak peek into the body to see how they work.
Explore GIDEON’s user-centric approach to transforming its interface to meet the diverse needs of modern clinical and academic users. Read a first-hand account from GIDEON Director, Product Development and Marketing, Kristina Symes.
Antiviral monoclonal antibody therapy is authorized for outpatients with mild-to-moderate COVID-19 at high risk for clinical progression. Read about this new therapy from the Infectious Disease team at DynaMed®.
Read about a new trial evaluating sotagliflozin in patients with diabetes and worsening heart failure, including threats to validity when protocols were amended mid-study.
Seven different COVID-19 vaccines are authorized around the world. Read about availability, vaccine types, vaccine efficacy, variants and vaccination precautions from the Infectious Disease team at DynaMed®.
High-quality randomized trials evaluating tocilizumab continue to show only modest effects in patients with severe COVID-19. Read about the latest trial in this EBM Focus article.
SARS-CoV-2 is mutating, as viruses do. Read about notable SARS-CoV-2 variants and their clinical impact from the Infectious Diseases team at DynaMed®.
Colonoscopy is the gold standard for colorectal cancer screening, but a variety of newer tests have been developed. Here the EBM Focus team discusses the options.